23911-26-4O=C(O)CN(CCN1CC(=O)OC(=O)C1)CCN1CC(=O)OC(=O)C1RAZLJUXJEOEYAM-UHFFFAOYSA-N23911-26-4DTXSID30178625Warning
H315 (97.8%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 05-10-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/20874
Glycine, N,N-bis2-(2,6-dioxo-4-morpholinyl)ethyl-: Does not have an individual approval but may be used under an appropriate group standard
UsesNSC 379317 or DTPAA is a useful synthetic intermediate in producing DPTA, in which it is used to synthesize the GO-DEN(Gd-DTPA)-mAb, a contrast reagent for prostate tumor MRI imaging. GO-DEN(Gd-DTPA)-mAb can be coupled with DOX to produce GO-DEN(Gd-DTPA)-mAb/DOX, creating an effective delivery of anti cancer drugs to the prostate cancer cells, PC-3, in mice.
Loading…